— Know what they know.
Not Investment Advice

NPCE NASDAQ

NeuroPace, Inc.
1W: +3.1% 1M: -4.1% 3M: +13.5% YTD: +7.3% 1Y: -9.5% 3Y: +281.3% 5Y: -22.1%
$16.92
+0.64 (+3.93%)
 
Weekly Expected Move ±9.9%
$12 $14 $15 $17 $18
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 48 · $576.9M mcap · 23M float · 0.899% daily turnover · Short 58% of daily vol

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$100M +25.1% ▲
5Y CAGR: +19.4%
Gross Profit
$77M +30.7% ▲
5Y CAGR: +20.6%
Operating Income
-$16M +24.6% ▲
Net Income
-$21M +20.9% ▲
EPS (Diluted)
$-0.66 +29.0% ▲
EBITDA
-$14M +13.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$45M$46M$65M$80M$100M
YoY Growth+9.8%+0.7%+43.7%+22.1%+25.1%
Cost of Revenue$12M$13M$17M$21M$23M
Gross Profit$33M$32M$48M$59M$77M
Gross Margin74.0%71.4%73.6%73.9%77.2%
R&D Expenses$18M$22M$21M$24M$28M
SG&A Expenses$39M$51M$55M$57M$66M
Operating Expenses$57M$73M$75M$81M$94M
Operating Income-$24M-$41M-$27M-$22M-$16M
Operating Margin-52.5%-89.6%-41.5%-27.1%-16.3%
Interest Expense$7M$8M$9M$9M$7M
Income Before Tax-$36M-$47M-$33M-$27M-$21M
Tax Expense$0$0$0$0$0
Net Income-$36M-$47M-$33M-$27M-$21M
Net Margin-79.9%-103.4%-50.4%-34.0%-21.5%
EPS (Diluted)$-2.17$-1.91$-1.27$-0.93$-0.66
EBITDA-$28M-$37M-$23M-$17M-$14M
Shares Outstanding17M25M26M29M33M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms